High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients
- 3 June 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Infection
- Vol. 81 (3), 420-426
- https://doi.org/10.1016/j.jinf.2020.05.067
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81600201, 81672025, 81702011, ZDX16004)
This publication has 20 references indexed in Scilit:
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected PneumoniaThe New England Journal of Medicine, 2020
- Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, ChinaJAMA, 2020
- Development and validation of different indirect ELISAs for MERS-CoV serological testingJournal of Immunological Methods, 2019
- Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivityClinical Microbiology & Infection, 2016
- Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in ChinaEmerging Microbes & Infections, 2016
- A Novel Rabbit Monoclonal Antibody Platform To Dissect the Diverse Repertoire of Antibody Epitopes for HIV-1 Env Immunogen DesignJournal of Virology, 2013
- SARS-CoV Antibody Prevalence in All Hong Kong Patient ContactsEmerging Infectious Diseases, 2004
- Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumoniaThe Lancet, 2004
- Healthcare Worker Seroconversion in SARS OutbreakEmerging Infectious Diseases, 2004
- Severe Acute Respiratory Syndrome–associated Coronavirus InfectionEmerging Infectious Diseases, 2003